PRS9 COST OF COMMUNITY ACQUIRED PNEUMONIA (CAP) TREATMENT WITH KETEK (TELITHROMYCIN) VS CLARITHROMYCIN FROM PUBLIC PAYER PERSPECTIVE IN POLAND
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67805-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)67805-9/fulltext
Section Title :
Section Order :
406
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67805-9&doi=10.1016/S1098-3015(10)67805-9